Neoepitope-specific T Cell Therapy for Blood Cancers Enters Clinical Trials
A clinical trial is underway to evaluate the efficacy of autologous T cells modified to target neoepitopes in patients with blood cancers.
Therapeutic Area
Therapeutic area intelligence for Cell Therapy with 5 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
A clinical trial is underway to collect peripheral blood mononuclear cells from healthy volunteers to expand T cells for adoptive cell therapy targeting tumors.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.